Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Marina Biotech, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Marina Biotech, Inc. - Product Pipeline Review - 2014', provides an overview of the Marina Biotech, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Marina Biotech, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Marina Biotech, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Marina Biotech, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Marina Biotech, Inc.'s pipeline products Reasons to buy - Evaluate Marina Biotech, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Marina Biotech, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Marina Biotech, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Marina Biotech, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Marina Biotech, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Marina Biotech, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Marina Biotech, Inc. Snapshot 5 Marina Biotech, Inc. Overview 5 Key Information 5 Key Facts 5 Marina Biotech, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Marina Biotech, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Marina Biotech, Inc. - Pipeline Products Glance 12 Marina Biotech, Inc. - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 Marina Biotech, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Marina Biotech, Inc. - Drug Profiles 14 CEQ-508 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 CEQ-501 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 MDR-09521 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 RNA Oligonucleotides to Inhibit Survivin for Hepatocellular Carcinoma 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 RNAi Oligonucleotide for Bladder Cancer 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 RNAi Oligonucleotide for Myotonic Dystrophy 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 RNAi Oligonucleotide to Inhibit MicroRNA-122 for Oncology 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 RNAi Oligonucleotide to Inhibit PLK1 for Malignant Ascites 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Marina Biotech, Inc. - Pipeline Analysis 22 Marina Biotech, Inc. - Pipeline Products by Target 22 Marina Biotech, Inc. - Pipeline Products by Route of Administration 23 Marina Biotech, Inc. - Pipeline Products by Molecule Type 24 Marina Biotech, Inc. - Pipeline Products by Mechanism of Action 25 Marina Biotech, Inc. - Recent Pipeline Updates 26 Marina Biotech, Inc. - Dormant Projects 29 Marina Biotech, Inc. - Locations And Subsidiaries 30 Head Office 30 Other Locations & Subsidiaries 30 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 32 Disclaimer 32
List of Tables Marina Biotech, Inc., Key Information 5 Marina Biotech, Inc., Key Facts 5 Marina Biotech, Inc. - Pipeline by Indication, 2014 7 Marina Biotech, Inc. - Pipeline by Stage of Development, 2014 8 Marina Biotech, Inc. - Monotherapy Products in Pipeline, 2014 9 Marina Biotech, Inc. - Partnered Products in Pipeline, 2014 10 Marina Biotech, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11 Marina Biotech, Inc. - Phase I, 2014 12 Marina Biotech, Inc. - Preclinical, 2014 13 Marina Biotech, Inc. - Pipeline by Target, 2014 22 Marina Biotech, Inc. - Pipeline by Route of Administration, 2014 23 Marina Biotech, Inc. - Pipeline by Molecule Type, 2014 24 Marina Biotech, Inc. - Pipeline Products by Mechanism of Action, 2014 25 Marina Biotech, Inc. - Recent Pipeline Updates, 2014 26 Marina Biotech, Inc. - Dormant Developmental Projects,2014 29 Marina Biotech, Inc., Subsidiaries 30
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.